We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$8.59B
AUM Growth
+$1.04B
Cap. Flow
+$618M
Cap. Flow %
7.2%
Top 10 Hldgs %
17.54%
Holding
2,356
New
64
Increased
649
Reduced
1,253
Closed
386

Top Sells

Rank Stock Value
1
BMS
Bemis
BMS
+$5.05M
2
SWKS icon
Skyworks Solutions
SWKS
+$4.16M
3
HBI
Hanesbrands
HBI
+$3.87M
4
AAP icon
Advance Auto Parts
AAP
+$3.77M
5
SLG icon
SL Green Realty
SLG
+$3.51M

Sector Composition

Rank Sector Weight
1 Technology 17.57%
2 Healthcare 15.92%
3 Financials 15.89%
4 Communication Services 8.09%
5 Industrials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCTX icon
1926
Lineage Cell Therapeutics
LCTX
$257M
$42K ﹤0.01%
13,846
-11,773
-46% -$31.8K
LEE icon
1927
Lee Enterprises
LEE
$166M
$42K ﹤0.01%
1,128
-977
-46% -$34.1K
RIGL icon
1928
Rigel Pharmaceuticals
RIGL
$680M
$42K ﹤0.01%
1,842
-6,119
-77% -$124K
BPTH
1929
DELISTED
Bio-Path Holdings Inc
BPTH
$42K ﹤0.01%
4
-3
-43% -$31K
SZYM
1930
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$42K ﹤0.01%
16,315
-13,862
-46% -$60.7K
SFY
1931
DELISTED
SWIFT ENERGY CO (HOLDING COMPANY)
SFY
$42K ﹤0.01%
10,348
-7,977
-44% -$47.7K
PALI icon
1932
Palisade Bio
PALI
$339M
0
RXII
1933
DELISTED
GALENA BIOPHARMA INC COM
RXII
$38K ﹤0.01%
25,343
-21,545
-46% -$32.3K
QUIK icon
1934
QuickLogic
QUIK
$224M
$37K ﹤0.01%
845
-719
-46% -$29.7K
MTEM
1935
DELISTED
Molecular Templates, Inc.
MTEM
$36K ﹤0.01%
68
-58
-46% -$29K
GST
1936
DELISTED
Gastar Exploration Inc.
GST
$36K ﹤0.01%
15,047
-6,786
-31% -$24.7K
ZGNX
1937
DELISTED
Zogenix, Inc.
ZGNX
$36K ﹤0.01%
3,297
-11,887
-78% -$118K
FRO icon
1938
Frontline
FRO
$8.75B
$35K ﹤0.01%
2,792
-2,415
-46% -$19.7K
EGIO
1939
DELISTED
Edgio, Inc. Common Stock
EGIO
$35K ﹤0.01%
317
-275
-46% -$28.1K
OCLR
1940
DELISTED
Oclaro Inc.
OCLR
$35K ﹤0.01%
19,703
-17,059
-46% -$28.7K
CORT icon
1941
Corcept Therapeutics
CORT
$10.2B
$34K ﹤0.01%
11,457
-9,744
-46% -$29.7K
HERO
1942
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
$34K ﹤0.01%
33,812
-29,264
-46% -$42.8K
MCP
1943
DELISTED
MOLYCORP INC COM STK
MCP
$34K ﹤0.01%
38,316
-33,164
-46% -$38.1K
CASC
1944
DELISTED
Cascadian Therapeutics, Inc.
CASC
$33K ﹤0.01%
2,890
-1,794
-38% -$19.5K
AOI
1945
DELISTED
Alliance One International
AOI
$33K ﹤0.01%
2,067
-1,605
-44% -$29.9K
TSYS
1946
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
$32K ﹤0.01%
10,135
-8,774
-46% -$26.1K
SPDC
1947
DELISTED
SPEED COMMERCE, INC COM STK
SPDC
$32K ﹤0.01%
10,432
-8,901
-46% -$24.8K
CYTR
1948
DELISTED
CytRx Corp
CYTR
$32K ﹤0.01%
1,968
-1,695
-46% -$26.4K
VIRX
1949
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$27K ﹤0.01%
51
-43
-46% -$19.4K
CNVS icon
1950
Cineverse
CNVS
$55M
$26K ﹤0.01%
81
-70
-46% -$22.6K

Similar funds

ProShare Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, ProShare Advisors held 2,356 positions worth $8.59B, up 14% from $7.54B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

ProShare Advisors deployed $618M of net new capital in Q4 2014, opening 64 new positions and adding to 649 existing holdings. Its largest new stake was Liberty Global Class C: 287,742 shares worth $11.2M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Bemis, an estimated $5.05M trimmed.

  • ProShare Advisors's largest Q4 2014 buy was Liberty Global Class C: 287,742 shares worth $11.2M.
  • ProShare Advisors added most to Apple in Q4 2014, an estimated $68.6M increase.
  • ProShare Advisors's biggest Q4 2014 reduction was Bemis, cutting an estimated $5.05M.
  • ProShare Advisors fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $3.32M.
  • ProShare Advisors's ten largest holdings make up 18% of its $8.59B portfolio in Q4 2014.
  • ProShare Advisors opened 64 new positions and closed 386 in Q4 2014.
  • ProShare Advisors's portfolio value rose 14% quarter-over-quarter to $8.59B.

Based on ProShare Advisors's 13F filing for Q4 2014, filed 30 Jan 2015.